Want to join the conversation?
$AVAV remains committed to generating revenue of $260-280MM, and EPS of $0.20-0.35 for FY17. Seasonally low 1Q17 revenue, lower than planned bookings and significant international opportunities requiring export license approval contribute to greater execution challenges, the company said.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?